Ledger.Open graph →
SEC Form D · filed September 23, 2016

Dova Pharmaceuticals, Inc

Offering
$40.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Paul B. Manning · Charlottesville, VAExec · Director · PromoterJames C. Reebals · Charlottesville, VAExec · PromoterDamian R. Degoa · Charlottesville, VAExec · PromoterBKB Growth Investments, LLC · Charlottesville, VAPromoterPrasad Phatak · New York, NYExec · PromoterJoshua Sherman · Menlo Park, CAExec · Director · PromoterRussell T. Schundler · Charlottesville, VAExec · PromoterPBM Capital Investments LLC · Charlottesville, VAPromoterHossein T. Ekrami · New York, NYDirectorEugene R. Scavola · Charlottesville, VAExec · PromoterJohn A. Stalfort · Charlottesville, VAExec · Director · PromoterArthur M. Krieg · Cambridge, MAExec · PromoterScott Lenet · Los Angeles, CAExec · Director · PromoterRussell T. Schundler · Charlottesville, VAExec · PromoterPBM Capital Investments LLC · Charlottesville, VAPromoterHossein T. Ekrami · New York, NYDirectorEugene R. Scavola · Charlottesville, VAExec · PromoterJohn A. Stalfort · Charlottesville, VAExec · Director · PromoterDamian R. Degoa · Charlottesville, VAExec · PromoterBKB Growth Investments, LLC · Charlottesville, VAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗